LAJIN ENT (08172) announced that after careful consideration of relevant factors, the company has decided not to exercise its right to refer the GEM Listing Committee's decision to the GEM Listing Review Committee. Consequently, trading of its shares will be suspended on the Stock Exchange starting at 9:00 a.m. on November 13, 2025, and will remain suspended until further notice.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.